These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1060 related items for PubMed ID: 26121913

  • 21. Cancers attributable to human papillomavirus infection.
    Grulich AE, Jin F, Conway EL, Stein AN, Hocking J.
    Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211
    [Abstract] [Full Text] [Related]

  • 22. A review of clinical trials of human papillomavirus prophylactic vaccines.
    Schiller JT, Castellsagué X, Garland SM.
    Vaccine; 2012 Nov 20; 30 Suppl 5(0 5):F123-38. PubMed ID: 23199956
    [Abstract] [Full Text] [Related]

  • 23. Association of human papillomavirus with vulvar and vaginal intraepithelial disease: opportunities for prevention.
    Pearson JM, Feltman RS, Twiggs LB.
    Womens Health (Lond); 2008 Mar 20; 4(2):143-50. PubMed ID: 19072516
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX, Retrospective International Survey and HPV Time Trends Study Group.
    Lancet Oncol; 2010 Nov 20; 11(11):1048-56. PubMed ID: 20952254
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States.
    Insinga RP, Liaw KL, Johnson LG, Madeleine MM.
    Cancer Epidemiol Biomarkers Prev; 2008 Jul 20; 17(7):1611-22. PubMed ID: 18628412
    [Abstract] [Full Text] [Related]

  • 29. [HPV DNA genotyping: A study of anogenital, head and neck and skin cancers in a population from west Algerian. HPV detection in different cancers from an Algerian population].
    Nahet A, Boublenza L, Hassaine H, Masdoua N, Prétet JL, Belglaiaa E, Mougin C.
    Bull Cancer; 2016 May 20; 103(5):455-60. PubMed ID: 27085765
    [Abstract] [Full Text] [Related]

  • 30. Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: the potential impact of different cross-protection profiles.
    Capri S, Gasparini R, Panatto D, Demarteau N.
    Gynecol Oncol; 2011 Jun 01; 121(3):514-21. PubMed ID: 21334734
    [Abstract] [Full Text] [Related]

  • 31. Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.
    Mariani L, Monfulleda N, Alemany L, Vizza E, Marandino F, Vocaturo A, Benevolo M, Quirós B, Lloveras B, Klaustermeier JE, Quint W, de Sanjosé S, Bosch FX.
    BMC Cancer; 2010 Jun 04; 10():259. PubMed ID: 20525370
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions.
    Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Dillner J, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Maansson R, Lu S, Vuocolo S, Hesley TM, Saah A, Barr E, Haupt RM.
    Cancer Prev Res (Phila); 2009 Oct 04; 2(10):868-78. PubMed ID: 19789295
    [Abstract] [Full Text] [Related]

  • 35. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
    Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT, HPV Typing of Cancers Workgroup.
    J Natl Cancer Inst; 2015 Jun 04; 107(6):djv086. PubMed ID: 25925419
    [Abstract] [Full Text] [Related]

  • 36. High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine.
    Hooi DJ, Lissenberg-Witte BI, de Koning MNC, Pinedo HM, Kenter GG, Meijer CJ, Quint WG.
    Sex Transm Infect; 2018 Jun 04; 94(4):263-267. PubMed ID: 29021405
    [Abstract] [Full Text] [Related]

  • 37. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
    Malinova M.
    Akush Ginekol (Sofiia); 2015 Jun 04; 54 Suppl 1():25-31. PubMed ID: 26137767
    [Abstract] [Full Text] [Related]

  • 38. HIV-positive women with anal high-grade squamous intraepithelial lesions: a study of 153 cases with long-term anogenital surveillance.
    Liu Y, Prasad-Hayes M, Ganz EM, Poggio JL, Lenskaya V, Malcolm T, Deshmukh A, Zheng W, Sigel K, Gaisa MM.
    Mod Pathol; 2020 Aug 04; 33(8):1589-1594. PubMed ID: 32152521
    [Abstract] [Full Text] [Related]

  • 39. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva.
    de Sanjosé S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, Joura EA, Maldonado P, Laco J, Bravo IG, Vidal A, Guimerà N, Cross P, Wain GV, Petry KU, Mariani L, Bergeron C, Mandys V, Sica AR, Félix A, Usubutun A, Seoud M, Hernández-Suárez G, Nowakowski AM, Wilson G, Dalstein V, Hampl M, Kasamatsu ES, Lombardi LE, Tinoco L, Alvarado-Cabrero I, Perrotta M, Bhatla N, Agorastos T, Lynch CF, Goodman MT, Shin HR, Viarheichyk H, Jach R, Cruz MO, Velasco J, Molina C, Bornstein J, Ferrera A, Domingo EJ, Chou CY, Banjo AF, Castellsagué X, Pawlita M, Lloveras B, Quint WG, Muñoz N, Bosch FX, HPV VVAP study group.
    Eur J Cancer; 2013 Nov 04; 49(16):3450-61. PubMed ID: 23886586
    [Abstract] [Full Text] [Related]

  • 40. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
    Zhao FH, Zhu FC, Chen W, Li J, Hu YM, Hong Y, Zhang YJ, Pan QJ, Zhu JH, Zhang X, Chen Y, Tang H, Zhang H, Durand C, Datta SK, Struyf F, Bi D, HPV-039 study group.
    Int J Cancer; 2014 Dec 01; 135(11):2604-11. PubMed ID: 24740547
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.